Huberman Lab
Dr. Matthew Hill: How Cannabis Impacts Health & the Potential Risks
Dr. Matthew Hill
It's high affinity. So it has the ability... But the tricky thing with that is... It can out-compete 2-AG, but because it's a lower efficacy agonist than 2-AG, in that sense, it's almost blocking the effects, not amplifying them.
0
💬
0
Comments
Log in to comment.
There are no comments yet.